For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231215:nRSO9016Wa&default-theme=true
RNS Number : 9016W PureTech Health PLC 15 December 2023
15 December 2023
PureTech Health plc
Transaction in Own Shares
PureTech Health PLC (the "Company") announces that it has purchased the
following number of its ordinary shares of one pence each through Jefferies
International Limited ("Jefferies"), as part of its Share Buyback Programme,
details of which were announced on 9 May 2022.
Date of purchase: 14 December 2023
Number of ordinary shares purchased: 74,441
Highest price paid per share: 148.80p
Lowest price paid per share: 141.80p
Volume weighted average price paid per share: 145.52p
PureTech intends to retain the purchased shares in treasury.
Following the above transaction, the Company will have 17,250,789 ordinary
shares in treasury and has 272,217,370 ordinary shares in issue (excluding
treasury shares). The total number of voting rights in the Company is
therefore 272,217,370 which may be used by shareholders in their calculations
to determine if they are required to notify their interest in, or a change to
their interest in, PureTech Health plc under the FCA's Disclosure Guidance and
Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as
incorporated into UK domestic law by the European Union (Withdrawal) Act 2018)
(the Market Abuse Regulation), detailed information about the individual
purchases is available below.
About PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated to giving life
to new classes of medicine to change the lives of patients with devastating
diseases. The Company has created a broad and deep pipeline through its
experienced research and development team and its extensive network of
scientists, clinicians and industry leaders that is being advanced both
internally and through its Founded Entities. PureTech's R&D engine has
resulted in the development of 27 therapeutics and therapeutic candidates,
including two (Plenity® and EndeavorRx®) that have received both U.S.
FDA clearance and European marketing authorization and a third (KarXT) that
has been filed for FDA approval. A number of these programs are being advanced
by PureTech or its Founded Entities in various indications and stages of
clinical development, including registration enabling studies. All of the
underlying programs and platforms that resulted in this pipeline of
therapeutic candidates were initially identified or discovered and then
advanced by the PureTech team through key validation points.
For more information, visit www.puretechhealth.com
(http://www.puretechhealth.com/) or connect with us on X, formerly known as
Twitter, @puretechh.
Contact:
PureTech
Investor Relations
IR@puretechhealth.com
Individual Transactions
Transaction Date Transaction Time Volume Price (GBp) Platform Transaction Reference Number
14/12/2023 08:19:38 94 147.2 AQXE 00382256782TRLO0.1.1
14/12/2023 08:19:38 195 147.2 AQXE 00382256783TRLO0.1.1
14/12/2023 08:19:38 1350 147.2 XLON 00382256784TRLO0.1.1
14/12/2023 08:21:52 675 147 CHIX 00382257641TRLO0.1.1
14/12/2023 08:21:52 675 147 XLON 00382257642TRLO0.1.1
14/12/2023 08:21:52 33 147 XLON 00382257643TRLO0.1.1
14/12/2023 08:34:27 642 146.8 XLON 00382261615TRLO0.1.1
14/12/2023 08:52:21 569 147 BATE 00382266561TRLO0.1.1
14/12/2023 08:52:21 675 147 CHIX 00382266559TRLO0.1.1
14/12/2023 08:52:21 142 147 TRQX 00382266562TRLO0.1.1
14/12/2023 08:52:21 675 147.2 XLON 00382266563TRLO0.1.1
14/12/2023 08:52:21 675 147.2 XLON 00382266564TRLO0.1.1
14/12/2023 09:21:06 89 146.8 XLON 00382274195TRLO0.1.1
14/12/2023 09:27:23 570 147 XLON 00382275773TRLO0.1.1
14/12/2023 09:27:23 691 147 XLON 00382275774TRLO0.1.1
14/12/2023 09:28:02 675 147 XLON 00382276077TRLO0.1.1
14/12/2023 09:41:01 675 148 XLON 00382279238TRLO0.1.1
14/12/2023 09:44:02 675 148 XLON 00382279879TRLO0.1.1
14/12/2023 09:51:44 561 148 XLON 00382281767TRLO0.1.1
14/12/2023 09:58:28 572 147.4 CHIX 00382283288TRLO0.1.1
14/12/2023 09:58:28 103 147.4 CHIX 00382283289TRLO0.1.1
14/12/2023 09:58:28 1350 147.4 XLON 00382283290TRLO0.1.1
14/12/2023 10:22:05 789 148 XLON 00382288624TRLO0.1.1
14/12/2023 10:32:16 674 148 XLON 00382290353TRLO0.1.1
14/12/2023 10:32:16 1 148 XLON 00382290354TRLO0.1.1
14/12/2023 11:51:36 117 148.8 TRQX 00382310313TRLO0.1.1
14/12/2023 11:51:36 61 148.8 BATE 00382310314TRLO0.1.1
14/12/2023 11:51:36 25 148.8 TRQX 00382310315TRLO0.1.1
14/12/2023 11:51:36 120 148.6 AQXE 00382310316TRLO0.1.1
14/12/2023 11:51:36 502 148.8 CHIX 00382310317TRLO0.1.1
14/12/2023 11:51:36 173 148.8 CHIX 00382310318TRLO0.1.1
14/12/2023 11:51:36 79 148.8 BATE 00382310319TRLO0.1.1
14/12/2023 11:51:36 162 148.8 BATE 00382310321TRLO0.1.1
14/12/2023 11:51:36 267 148.8 BATE 00382310320TRLO0.1.1
14/12/2023 11:51:36 675 148.8 XLON 00382310322TRLO0.1.1
14/12/2023 11:51:36 169 148.6 AQXE 00382310323TRLO0.1.1
14/12/2023 11:51:36 2 148.6 AQXE 00382310325TRLO0.1.1
14/12/2023 11:51:36 10 148.6 AQXE 00382310324TRLO0.1.1
14/12/2023 11:51:36 28 148.6 AQXE 00382310326TRLO0.1.1
14/12/2023 12:02:35 675 148.4 XLON 00382313704TRLO0.1.1
14/12/2023 12:30:51 675 148.2 XLON 00382321094TRLO0.1.1
14/12/2023 12:30:51 189 148.2 XLON 00382321095TRLO0.1.1
14/12/2023 13:14:24 249 147.2 AQXE 00382332298TRLO0.1.1
14/12/2023 13:14:24 273 147.2 CHIX 00382332299TRLO0.1.1
14/12/2023 13:14:24 325 147.2 CHIX 00382332300TRLO0.1.1
14/12/2023 13:14:24 77 147.2 CHIX 00382332301TRLO0.1.1
14/12/2023 13:14:24 1836 147.2 XLON 00382332302TRLO0.1.1
14/12/2023 13:25:23 74 146.6 XLON 00382336061TRLO0.1.1
14/12/2023 13:28:22 675 146.6 CHIX 00382336717TRLO0.1.1
14/12/2023 13:28:22 135 146.6 CHIX 00382336718TRLO0.1.1
14/12/2023 13:28:22 15 146.6 BATE 00382336719TRLO0.1.1
14/12/2023 13:28:22 57 146.6 BATE 00382336721TRLO0.1.1
14/12/2023 13:28:22 569 146.6 BATE 00382336720TRLO0.1.1
14/12/2023 13:28:22 142 146.6 TRQX 00382336722TRLO0.1.1
14/12/2023 13:28:22 15 146.6 TRQX 00382336723TRLO0.1.1
14/12/2023 13:28:22 1951 146.6 XLON 00382336724TRLO0.1.1
14/12/2023 13:29:39 21 146 XLON 00382337115TRLO0.1.1
14/12/2023 13:29:39 250 146 XLON 00382337114TRLO0.1.1
14/12/2023 13:48:03 615 147 XLON 00382343724TRLO0.1.1
14/12/2023 13:48:03 1139 147 XLON 00382343725TRLO0.1.1
14/12/2023 13:48:42 2025 146.8 XLON 00382343968TRLO0.1.1
14/12/2023 14:11:11 825 147 XLON 00382353621TRLO0.1.1
14/12/2023 14:11:11 1200 147 XLON 00382353622TRLO0.1.1
14/12/2023 14:17:02 540 147 CHIX 00382356099TRLO0.1.1
14/12/2023 14:17:04 1350 147 XLON 00382356113TRLO0.1.1
14/12/2023 14:17:10 13 146.8 XLON 00382356135TRLO0.1.1
14/12/2023 14:17:10 218 146.8 XLON 00382356134TRLO0.1.1
14/12/2023 14:17:10 1067 146.8 XLON 00382356136TRLO0.1.1
14/12/2023 14:17:10 727 146.8 XLON 00382356138TRLO0.1.1
14/12/2023 14:19:24 297 146.8 CHIX 00382356944TRLO0.1.1
14/12/2023 14:19:24 675 146.8 CHIX 00382356946TRLO0.1.1
14/12/2023 14:19:24 378 146.8 CHIX 00382356945TRLO0.1.1
14/12/2023 14:21:12 675 146.8 XLON 00382357453TRLO0.1.1
14/12/2023 14:21:12 43 146.6 BATE 00382357454TRLO0.1.1
14/12/2023 14:21:12 454 146.6 BATE 00382357455TRLO0.1.1
14/12/2023 14:21:12 88 146.6 TRQX 00382357457TRLO0.1.1
14/12/2023 14:21:12 348 146.6 BATE 00382357456TRLO0.1.1
14/12/2023 14:21:12 127 146.6 TRQX 00382357458TRLO0.1.1
14/12/2023 14:21:13 621 146.2 XLON 00382357467TRLO0.1.1
14/12/2023 14:21:39 585 145 AQXE 00382357843TRLO0.1.1
14/12/2023 14:28:40 729 142.4 XLON 00382360651TRLO0.1.1
14/12/2023 14:28:40 529 142.2 XLON 00382360652TRLO0.1.1
14/12/2023 14:33:32 675 142 CHIX 00382365792TRLO0.1.1
14/12/2023 14:33:33 821 142 XLON 00382365793TRLO0.1.1
14/12/2023 14:33:36 675 142 XLON 00382365814TRLO0.1.1
14/12/2023 14:33:37 202 141.8 XLON 00382365840TRLO0.1.1
14/12/2023 14:42:19 675 143 CHIX 00382373928TRLO0.1.1
14/12/2023 14:42:20 1327 143 XLON 00382373946TRLO0.1.1
14/12/2023 14:42:20 2048 142.6 XLON 00382373958TRLO0.1.1
14/12/2023 14:42:25 902 142.4 XLON 00382374000TRLO0.1.1
14/12/2023 14:42:27 790 142 BATE 00382374032TRLO0.1.1
14/12/2023 14:42:27 196 142 TRQX 00382374033TRLO0.1.1
14/12/2023 14:43:56 282 143 AQXE 00382375170TRLO0.1.1
14/12/2023 14:44:26 518 142 XLON 00382375512TRLO0.1.1
14/12/2023 14:51:39 675 143 CHIX 00382381469TRLO0.1.1
14/12/2023 14:56:02 929 143.2 XLON 00382385352TRLO0.1.1
14/12/2023 15:20:22 672 143.8 CHIX 00382404486TRLO0.1.1
14/12/2023 15:20:22 3 143.8 CHIX 00382404488TRLO0.1.1
14/12/2023 15:31:49 250 144.8 CHIX 00382413928TRLO0.1.1
14/12/2023 15:31:49 370 144.8 CHIX 00382413929TRLO0.1.1
14/12/2023 15:31:50 328 144.2 BATE 00382413951TRLO0.1.1
14/12/2023 15:31:50 595 144.2 CHIX 00382413952TRLO0.1.1
14/12/2023 15:31:50 115 144.2 AQXE 00382413953TRLO0.1.1
14/12/2023 15:31:50 85 144.2 AQXE 00382413954TRLO0.1.1
14/12/2023 15:31:50 190 144.2 CHIX 00382413956TRLO0.1.1
14/12/2023 15:31:50 241 144.2 BATE 00382413955TRLO0.1.1
14/12/2023 15:31:50 565 144.2 CHIX 00382413957TRLO0.1.1
14/12/2023 15:31:50 142 144.2 TRQX 00382413958TRLO0.1.1
14/12/2023 15:31:50 877 144.2 XLON 00382413959TRLO0.1.1
14/12/2023 15:31:50 1823 144.2 XLON 00382413960TRLO0.1.1
14/12/2023 15:31:58 89 144.2 AQXE 00382414112TRLO0.1.1
14/12/2023 15:31:58 40 144.2 AQXE 00382414111TRLO0.1.1
14/12/2023 15:35:10 425 144.2 XLON 00382416729TRLO0.1.1
14/12/2023 15:37:28 569 144.2 BATE 00382418634TRLO0.1.1
14/12/2023 15:37:28 1600 144.2 XLON 00382418635TRLO0.1.1
14/12/2023 15:37:28 1100 144.2 XLON 00382418636TRLO0.1.1
14/12/2023 15:38:34 160 144.2 AQXE 00382419440TRLO0.1.1
14/12/2023 15:38:34 142 143.8 TRQX 00382419441TRLO0.1.1
14/12/2023 15:38:34 2700 143.8 XLON 00382419442TRLO0.1.1
14/12/2023 15:44:51 440 143.4 XLON 00382424825TRLO0.1.1
14/12/2023 15:47:57 2896 144.4 XLON 00382426868TRLO0.1.1
14/12/2023 15:47:57 1788 144.4 XLON 00382426870TRLO0.1.1
14/12/2023 15:55:03 1731 144.4 XLON 00382432329TRLO0.1.1
14/12/2023 16:07:31 730 145 CHIX 00382442508TRLO0.1.1
14/12/2023 16:22:52 2700 145.4 XLON 00382456147TRLO0.1.1
14/12/2023 16:22:57 674 145.8 CHIX 00382456218TRLO0.1.1
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSFLFSDFELSLIV